| 1 | Ultra-Processed Food Intake as an Effect Modifier in the Association Between Depression and Diabetes in Brazil: A Cross-Sectional Study | 4.4 | 0 | Citations (PDF) |
| 2 | Ultra-processed foods and dopamine: Parsing complexity beyond observed variability | 25.2 | 1 | Citations (PDF) |
| 3 | Vitamin D serum concentration is prospectively associated with depressive symptoms in the EpiFloripa Aging Cohort Study: a structural equation modeling approach | 0.9 | 1 | Citations (PDF) |
| 4 | Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics | 2.4 | 10 | Citations (PDF) |
| 5 | Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design | 3.4 | 2 | Citations (PDF) |
| 6 | Nutrition and bipolar disorder: a systematic review | 3.6 | 51 | Citations (PDF) |
| 7 | Effects of the ketogenic diet on cognition: a systematic review | 3.6 | 34 | Citations (PDF) |
| 8 | Correlation between improved leptin signaling and cognitive function post bariatric surgery | 4.5 | 12 | Citations (PDF) |
| 9 | Association between adiposity and emergent depressive symptoms in a 10-years prospective cohort of older adults: The EpiFloripa Aging study | 4.5 | 3 | Citations (PDF) |
| 10 | Does the Ranking Matter? A Retrospective Cohort Study Investigating the Impact of the
2018 CANMAT and ISBD Guidelines for the Management of Patients with Bipolar Disorder
Treatment Recommendations for Acute Mania on Rehospitalization Rates | 2.7 | 2 | Citations (PDF) |
| 11 | Practices, knowledge, and attitudes about lithium treatment: Results of online surveys completed by clinicians and lithium-treated patients | 2.9 | 4 | Citations (PDF) |
| 12 | The effect of lifestyle interventions on depressive symptom severity in individuals with type-2 diabetes: A meta-analysis of randomized controlled trials | 2.1 | 8 | Citations (PDF) |
| 13 | Euthymic and depressed bipolar patients are characterized by different RNA editing patterns in blood | 3.1 | 7 | Citations (PDF) |
| 14 | Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis | 3.9 | 23 | Citations (PDF) |
| 15 | Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis | 4.5 | 15 | Citations (PDF) |
| 16 | What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines | 4.5 | 22 | Citations (PDF) |
| 17 | Misinformation in nutrition through the case of coconut oil: An online before-and-after study | 3.2 | 10 | Citations (PDF) |
| 18 | A call for improving lithium literacy among clinicians and patients | 2.1 | 10 | Citations (PDF) |
| 19 | Microbiome abnormalities as a possible link between diabetes mellitus and mood disorders: Pathophysiology and implications for treatment | 6.8 | 15 | Citations (PDF) |
| 20 | Is subthreshold depression in adolescence clinically relevant? | 4.5 | 98 | Citations (PDF) |
| 21 | A Possible Antidepressive Effect of Dietary Interventions: Emergent Findings and Research Challenges | 2.1 | 16 | Citations (PDF) |
| 22 | Smartphone‐based interventions in bipolar disorder: Systematic review and meta‐analyses of efficacy. A position paper from the International Society for Bipolar Disorders (ISBD) Big Data Task Force | 2.1 | 46 | Citations (PDF) |
| 23 | Conflicts of interest in invasive brain stimulation research | 0.9 | 0 | Citations (PDF) |
| 24 | Is there a place for dietetic interventions in adult ADHD? | 3.8 | 12 | Citations (PDF) |
| 25 | The Interactions Between Vulnerabilities for HIV and Syphilis among Cisgender and Transgender People Who Use Drugs | 1.9 | 4 | Citations (PDF) |
| 26 | Effects of transcranial direct current stimulation associated with hypocaloric diet on glucose homeostasis in obesity | 4.0 | 2 | Citations (PDF) |
| 27 | Psychiatric profile and quality of life of subjects with excess weight treated with transcranial direct current stimulation combined with a hypocaloric diet | 3.6 | 7 | Citations (PDF) |
| 28 | Characterizing the gut microbiota in adults with bipolar disorder: a pilot study | 3.6 | 61 | Citations (PDF) |
| 29 | Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian Rapid Treatment Center of Excellence | 3.8 | 17 | Citations (PDF) |
| 30 | Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin | 2.9 | 53 | Citations (PDF) |
| 31 | Effects of infliximab on brain neurochemistry of adults with bipolar depression | 4.5 | 15 | Citations (PDF) |
| 32 | Peripheral inflammatory biomarkers define biotypes of bipolar depression | 7.8 | 42 | Citations (PDF) |
| 33 | Ecological momentary assessment of depressive symptoms using the mind.me application: Convergence with the Patient Health Questionnaire-9 (PHQ-9) | 2.9 | 30 | Citations (PDF) |
| 34 | Recent Advances in Biomarkers of Addiction: A Narrative Review | 0.4 | 4 | Citations (PDF) |
| 35 | Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review | 2.9 | 61 | Citations (PDF) |
| 36 | Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation | 8.8 | 636 | Citations (PDF) |
| 37 | Is Obesity A Determinant Of Success With Pharmacological Treatment For Depression? A Systematic Review, Meta-Analysis And Meta-Regression. | 4.5 | 32 | Citations (PDF) |
| 38 | Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries | 4.5 | 213 | Citations (PDF) |
| 39 | The importance of countertransference in the clinical care of individuals during acute phases of bipolar disorder | 2.1 | 2 | Citations (PDF) |
| 40 | Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force | 2.1 | 47 | Citations (PDF) |
| 41 | Why do medications with little or no efficacy continue to be prescribed in the management of patients with bipolar disorder? | 2.1 | 3 | Citations (PDF) |
| 42 | Clinical effectiveness of non-TMS neurostimulation in depression: Clinical trials from 2010 to 2020 | 3.8 | 10 | Citations (PDF) |
| 43 | Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings | 7.8 | 42 | Citations (PDF) |
| 44 | Inflammation, brain structure and cognition interrelations among individuals with differential risks for bipolar disorder | 4.5 | 24 | Citations (PDF) |
| 45 | Barriers to care and psychopathology among Bolivian migrants living in São Paulo, Brazil | 2.2 | 10 | Citations (PDF) |
| 46 | A discussion of potential clinical markers predicting anti-inflammatory treatment response in individuals with major depression | 4.5 | 0 | Citations (PDF) |
| 47 | Parsing metabolic heterogeneity in mood disorders: A hypothesis‐driven cluster analysis of glucose and insulin abnormalities | 2.1 | 20 | Citations (PDF) |
| 48 | Neuroinflammation and glial cell activation in mental disorders | 2.4 | 46 | Citations (PDF) |
| 49 | Neuropeptides and oligopeptidases in schizophrenia | 6.8 | 37 | Citations (PDF) |
| 50 | Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis | 7.8 | 27 | Citations (PDF) |
| 51 | The effect of transcranial direct current stimulation along with a hypocaloric diet on weight loss in excessive weight people: A pilot randomized clinical trial | 0.7 | 9 | Citations (PDF) |
| 52 | Clinical correlates of high burden of general medical comorbidities in patients with bipolar disorder | 1.2 | 3 | Citations (PDF) |
| 53 | Bipolar disorders | 62.1 | 928 | Citations (PDF) |
| 54 | From Speech Illusions to Onset of Psychotic Disorder: Applying Network Analysis to an Experimental Measure of Aberrant Experiences | 1.4 | 5 | Citations (PDF) |
| 55 | Allostatic load, emotional hyper‐reactivity, and functioning in individuals with bipolar disorder | 2.1 | 28 | Citations (PDF) |
| 56 | The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence | 4.5 | 104 | Citations (PDF) |
| 57 | Caloric restriction, resting metabolic rate and cognitive performance in Non-obese adults: A post-hoc analysis from CALERIE study | 2.9 | 17 | Citations (PDF) |
| 58 | Effect of body anthropometrics on brain structure of offspring of parents with bipolar disorder | 2.9 | 1 | Citations (PDF) |
| 59 | Gene expression changes associated with trajectories of psychopathology in a longitudinal cohort of children and adolescents | 5.2 | 12 | Citations (PDF) |
| 60 | Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression | 2.7 | 19 | Citations (PDF) |
| 61 | Three insights on psychoneuroimmunology of mood disorders to be taken from the COVID-19 pandemic | 2.4 | 19 | Citations (PDF) |
| 62 | What is bipolar disorder? A disease model of dysregulated energy expenditure | 6.8 | 30 | Citations (PDF) |
| 63 | Mental, emotional, and behavioral effects of ketogenic diet for non-epileptic neuropsychiatric conditions | 3.8 | 25 | Citations (PDF) |
| 64 | Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression | 4.6 | 59 | Citations (PDF) |
| 65 | Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels | 3.7 | 52 | Citations (PDF) |
| 66 | Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression | 4.5 | 68 | Citations (PDF) |
| 67 | Exploring the mechanisms of action of the antidepressant effect of the ketogenic diet | 3.6 | 37 | Citations (PDF) |
| 68 | Is bipolar disorder associated with premature aging? | 0.8 | 5 | Citations (PDF) |
| 69 | Development and implementation of guidelines for the management of depression: a systematic review | 2.0 | 39 | Citations (PDF) |
| 70 | The potential anti-depressant properties of dexmedetomidine infusion: a review of mechanistic, preclinical, and clinical evidence | 3.6 | 10 | Citations (PDF) |
| 71 | Peripheral interleukin-6 levels and working memory in non-obese adults: A post-hoc analysis from the CALERIE study | 2.7 | 11 | Citations (PDF) |
| 72 | Integrating digital phenotyping in clinical characterization of individuals with mood disorders | 6.8 | 63 | Citations (PDF) |
| 73 | Teaching how to deliver bad news: a systematic review | 0.2 | 35 | Citations (PDF) |
| 74 | Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents | 3.4 | 27 | Citations (PDF) |
| 75 | Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants | 3.8 | 42 | Citations (PDF) |
| 76 | Machine learning and big data analytics in bipolar disorder: A position paper from the International Society for Bipolar Disorders Big Data Task Force | 2.1 | 90 | Citations (PDF) |
| 77 | Detecting multiple differentially methylated CpG sites and regions related to dimensional psychopathology in youths | 3.9 | 26 | Citations (PDF) |
| 78 | Intra-individual variability in animal models of bipolar disorder | 2.1 | 2 | Citations (PDF) |
| 79 | Attenuated inflammatory response of monocyte-derived macrophage from patients with BD: a preliminary report | 2.1 | 18 | Citations (PDF) |
| 80 | Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder | 2.9 | 43 | Citations (PDF) |
| 81 | Acute neuroinflammation elicited by TLR-3 systemic activation combined with early life stress induces working memory impairments in male adolescent mice | 2.2 | 25 | Citations (PDF) |
| 82 | Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study | 5.2 | 77 | Citations (PDF) |
| 83 | Effort-based decision-making is affected by overweight/obesity in major depressive disorder | 4.5 | 35 | Citations (PDF) |
| 84 | Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression | 12.4 | 190 | Citations (PDF) |
| 85 | Stress, epigenetics and depression: A systematic review | 6.8 | 411 | Citations (PDF) |
| 86 | Pharmacological treatment for insomnia in patients with major depressive disorder | 2.1 | 21 | Citations (PDF) |
| 87 | Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders | 3.8 | 38 | Citations (PDF) |
| 88 | Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia | 2.3 | 18 | Citations (PDF) |
| 89 | Emotional intelligence and schizophrenia spectrum disorders: a critical review | 0.8 | 11 | Citations (PDF) |
| 90 | A critical literature review on emotional intelligence in addiction | 0.8 | 21 | Citations (PDF) |
| 91 | Suicidal behavior among substance users: data from the Second Brazilian National Alcohol and Drug Survey (II BNADS) | 0.9 | 44 | Citations (PDF) |
| 92 | The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders | 3.8 | 68 | Citations (PDF) |
| 93 | Association between spontaneous activity of the default mode network hubs and leukocyte telomere length in late childhood and early adolescence | 2.1 | 3 | Citations (PDF) |
| 94 | Serum metabolic profiling using small molecular water‐soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre–post‐treatment design | 3.3 | 32 | Citations (PDF) |
| 95 | Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review | 3.8 | 48 | Citations (PDF) |
| 96 | Hypersomnia and Bipolar Disorder: A systematic review and meta-analysis of proportion | 4.5 | 26 | Citations (PDF) |
| 97 | The long-term effect of bariatric surgery on depression and anxiety | 4.5 | 168 | Citations (PDF) |
| 98 | Hiccups amelioration following a transcranial direct current stimulation protocol targeting central structures | 2.4 | 1 | Citations (PDF) |
| 99 | The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders | 1.0 | 26 | Citations (PDF) |
| 100 | A pilot case-control study on the association between N-acetyl derivatives in serum and first-episode schizophrenia | 3.1 | 11 | Citations (PDF) |
| 101 | Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review | 3.8 | 161 | Citations (PDF) |
| 102 | Heterotypic trajectories of dimensional psychopathology across the lifespan: the case of youth‐onset attention deficit/hyperactivity disorder | 6.3 | 25 | Citations (PDF) |
| 103 | Comparison of serum essential trace metals between patients with schizophrenia and healthy controls | 3.0 | 41 | Citations (PDF) |
| 104 | Oligopeptidases activity in bipolar disorder: Ndel1 and angiotensin I converting enzyme | 4.5 | 16 | Citations (PDF) |
| 105 | Socioeconomic status in children is associated with spontaneous activity in right superior temporal gyrus | 2.1 | 9 | Citations (PDF) |
| 106 | New-onset psychiatric symptoms following intracranial meningioma in a patient with schizophrenia: a case study | 0.9 | 1 | Citations (PDF) |
| 107 | Polygenic Risk Score for Alzheimer’s Disease: Implications for Memory Performance and Hippocampal Volumes in Early Life | 8.8 | 92 | Citations (PDF) |
| 108 | Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists? | 4.3 | 37 | Citations (PDF) |
| 109 | An immunological age index in bipolar disorder: A confirmatory factor analysis of putative immunosenescence markers and associations with clinical characteristics | 2.2 | 20 | Citations (PDF) |
| 110 | The impact of body mass index in gene expression of reelin pathway mediators in individuals with schizophrenia and mood disorders: A post-mortem study | 2.9 | 6 | Citations (PDF) |
| 111 | Accessing Gene Expression in Treatment-Resistant Schizophrenia | 3.7 | 25 | Citations (PDF) |
| 112 | Non-invasive brain stimulation for negative symptoms in schizophrenia: An updated systematic review and meta-analysis | 2.3 | 97 | Citations (PDF) |
| 113 | Effects of the brain-derived neurotropic factor variant Val66Met on cortical structure in late childhood and early adolescence | 2.9 | 13 | Citations (PDF) |
| 114 | Targeting cytokines in reduction of depressive symptoms: A comprehensive review | 3.8 | 67 | Citations (PDF) |
| 115 | Alice in Wonderland syndrome secondary to optical neuromyelitis caused by varicella | 2.4 | 4 | Citations (PDF) |
| 116 | The differential association between history of childhood sexual abuse and body mass index in early and late stages of bipolar disorder | 4.5 | 21 | Citations (PDF) |
| 117 | Leukocyte telomere length variation in different stages of schizophrenia | 2.9 | 31 | Citations (PDF) |
| 118 | Gluten related illnesses and severe mental disorders: a comprehensive review | 6.8 | 34 | Citations (PDF) |
| 119 | Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review | 4.5 | 103 | Citations (PDF) |
| 120 | Expression of dopamine signaling genes in the post-mortem brain of individuals with mental illnesses is moderated by body mass index and mediated by insulin signaling genes | 2.9 | 27 | Citations (PDF) |
| 121 | Preliminary results from Brazil's first recovery housing program | 0.8 | 4 | Citations (PDF) |
| 122 | Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder | 2.4 | 227 | Citations (PDF) |
| 123 | Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression | 3.0 | 58 | Citations (PDF) |
| 124 | Effect of male-specific childhood trauma on telomere length | 2.9 | 12 | Citations (PDF) |
| 125 | Letter to the editor: Inadequate evidence to support improved patient outcomes with combinatorial pharmacogenomics | 2.9 | 1 | Citations (PDF) |
| 126 | Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study | 2.3 | 50 | Citations (PDF) |
| 127 | Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders | 3.8 | 45 | Citations (PDF) |
| 128 | Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments | 6.8 | 161 | Citations (PDF) |
| 129 | Predicting antidepressant response using early changes in cognition: A systematic review | 2.2 | 32 | Citations (PDF) |
| 130 | Stress, trauma, and posttraumatic stress disorder in migrants: a comprehensive review | 0.9 | 142 | Citations (PDF) |
| 131 | Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder | 2.9 | 113 | Citations (PDF) |
| 132 | Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism? | 4.5 | 119 | Citations (PDF) |
| 133 | Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review | 4.5 | 381 | Citations (PDF) |
| 134 | Leptin and adiponectin levels in major depressive disorder: A systematic review and meta-analysis | 4.5 | 91 | Citations (PDF) |
| 135 | Therapeutic potential of JAK/STAT pathway modulation in mood disorders | 3.6 | 55 | Citations (PDF) |
| 136 | Coronary calcium score as an expression of multisystemic progression of bipolar disorder | 0.9 | 2 | Citations (PDF) |
| 137 | Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders | 4.1 | 40 | Citations (PDF) |
| 138 | Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up | 2.3 | 86 | Citations (PDF) |
| 139 | Shorter leukocyte telomere length in patients at ultra high risk for psychosis | 1.0 | 27 | Citations (PDF) |
| 140 | Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders | 3.6 | 43 | Citations (PDF) |
| 141 | Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder | 3.3 | 16 | Citations (PDF) |
| 142 | 1H-NMR, 1H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profiling | 2.1 | 31 | Citations (PDF) |
| 143 | A pilot, open‐label, 8‐week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression | 2.1 | 47 | Citations (PDF) |
| 144 | Gene expression in blood of children and adolescents: Mediation between childhood maltreatment and major depressive disorder | 2.9 | 32 | Citations (PDF) |
| 145 | NMR Spectroscopy Metabolomics Applied to Crack Cocaine Users and Patients with Schizophrenia: Similar Behavior but Different Molecular Causes | 1.7 | 5 | Citations (PDF) |
| 146 | Recent advances in lipidomics: Analytical and clinical perspectives | 2.2 | 97 | Citations (PDF) |
| 147 | Metabolomics and lipidomics analyses by 1H nuclear magnetic resonance of schizophrenia patient serum reveal potential peripheral biomarkers for diagnosis | 2.3 | 43 | Citations (PDF) |
| 148 | Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems | 4.5 | 139 | Citations (PDF) |
| 149 | Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review | 2.1 | 59 | Citations (PDF) |
| 150 | BDNF and BMI effects on brain structures of bipolar offspring: results from the global mood and brain science initiative | 4.1 | 20 | Citations (PDF) |
| 151 | A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics | 3.1 | 44 | Citations (PDF) |
| 152 | N‐acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta‐analysis | 1.9 | 79 | Citations (PDF) |
| 153 | Treatment with a GLP−1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders | 1.0 | 67 | Citations (PDF) |
| 154 | Selfish brain and selfish immune system interplay: A theoretical framework for metabolic comorbidities of mood disorders | 6.8 | 28 | Citations (PDF) |
| 155 | Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study | 4.5 | 154 | Citations (PDF) |
| 156 | A critical review of trials of transcranial direct current stimulation and trigeminal nerve stimulation for depression: the issue of treatment-emergent mania | 0.8 | 12 | Citations (PDF) |
| 157 | Impact of inequalities in health care on the mortality risk of individuals with severe mental illnesses | 0.9 | 4 | Citations (PDF) |
| 158 | Challenges and developments in research of the early stages of bipolar disorder | 0.9 | 13 | Citations (PDF) |
| 159 | Hair cortisol in drug-naïve first-episode individuals with psychosis | 0.9 | 21 | Citations (PDF) |
| 160 | Measuring child maltreatment using multi-informant survey data: a higher-order confirmatory factor analysis | 0.8 | 31 | Citations (PDF) |
| 161 | Is semantic verbal fluency impairment explained by executive function deficits in schizophrenia? | 0.9 | 33 | Citations (PDF) |
| 162 | Serum copeptin in children exposed to maltreatment | 3.3 | 17 | Citations (PDF) |
| 163 | Inflammation, neurotrophism and oxidative stress and childhood psychopathology in a large community sample | 4.1 | 10 | Citations (PDF) |
| 164 | Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis | 5.2 | 29 | Citations (PDF) |
| 165 | Inter‐relation between brain‐derived neurotrophic factor and antioxidant enzymes in bipolar disorder | 2.1 | 18 | Citations (PDF) |
| 166 | Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis | 2.3 | 54 | Citations (PDF) |
| 167 | Distinct behavioral and immunoendocrine parameters during crack cocaine abstinence in women reporting childhood abuse and neglect | 2.9 | 38 | Citations (PDF) |
| 168 | An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity Disorder | 3.4 | 26 | Citations (PDF) |
| 169 | Crack cocaine addiction, early life stress and accelerated cellular aging among women | 3.8 | 36 | Citations (PDF) |
| 170 | Association of serum interleukin-6 with mental health problems in children exposed to perinatal complications and social disadvantage | 2.7 | 7 | Citations (PDF) |
| 171 | Bipolar disorder course, impaired glucose metabolism and antioxidant enzymes activities: A preliminary report | 2.9 | 16 | Citations (PDF) |
| 172 | Anti‐inflammatory agents in the treatment of bipolar depression: a systematic review and meta‐analysis | 2.1 | 188 | Citations (PDF) |
| 173 | Adipokines, metabolic dysfunction and illness course in bipolar disorder | 2.9 | 43 | Citations (PDF) |
| 174 | Impaired glucose metabolism moderates the course of illness in bipolar disorder | 4.5 | 40 | Citations (PDF) |
| 175 | The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder | 3.8 | 162 | Citations (PDF) |
| 176 | Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders | 2.7 | 105 | Citations (PDF) |
| 177 | Perinatal complications, lipid peroxidation, and mental health problems in a large community pediatric sample | 3.1 | 12 | Citations (PDF) |
| 178 | Socioeconomic Disadvantage Moderates the Association between Peripheral Biomarkers and Childhood Psychopathology | 2.3 | 19 | Citations (PDF) |
| 179 | Hippocampus size does not correlate with body mass index in bipolar disorder | 0.9 | 4 | Citations (PDF) |
| 180 | Circadian rhythm disturbances and conversion to psychosis in ultra high-risk youth | 0.9 | 5 | Citations (PDF) |
| 181 | It is time to prepare mental health services to attend to migrants and refugees | 0.9 | 6 | Citations (PDF) |
| 182 | Clinical characteristics and influence of childhood trauma on the prodrome of bipolar disorder | 0.9 | 23 | Citations (PDF) |
| 183 | Determinants of adherence to treatment in first-episode psychosis: a comprehensive review | 0.9 | 77 | Citations (PDF) |
| 184 | Early stages of bipolar disorder: characterization and strategies for early intervention | 0.9 | 22 | Citations (PDF) |
| 185 | Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression | 17.3 | 700 | Citations (PDF) |
| 186 | Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders | 6.8 | 297 | Citations (PDF) |
| 187 | Effects of Risperidone on Cytokine Profile in Drug-Naive First-Episode Psychosis | 2.7 | 89 | Citations (PDF) |
| 188 | High risk cohort study for psychiatric disorders in childhood: rationale, design, methods and preliminary results | 2.2 | 187 | Citations (PDF) |
| 189 | Is religiosity a protective factor against suicidal behavior in bipolar I outpatients? | 4.5 | 30 | Citations (PDF) |
| 190 | Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis | 2.3 | 36 | Citations (PDF) |
| 191 | Circadian rest–activity rhythm in individuals at risk for psychosis and bipolar disorder | 2.3 | 63 | Citations (PDF) |
| 192 | Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone | 2.9 | 64 | Citations (PDF) |
| 193 | Effects of depression on the cytokine profile in drug naïve first-episode psychosis | 2.3 | 56 | Citations (PDF) |
| 194 | Abnormalities in sleep patterns in individuals at risk for psychosis and bipolar disorder | 2.3 | 61 | Citations (PDF) |
| 195 | High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance | 4.1 | 96 | Citations (PDF) |
| 196 | Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naïve patients with first-episode psychosis | 1.0 | 24 | Citations (PDF) |
| 197 | Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications | 4.5 | 158 | Citations (PDF) |
| 198 | Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia | 3.1 | 25 | Citations (PDF) |
| 199 | Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls | 1.9 | 19 | Citations (PDF) |
| 200 | Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis | 3.7 | 63 | Citations (PDF) |
| 201 | Omics-based depression and inflammation research | 0.9 | 11 | Citations (PDF) |
| 202 | Childhood Trauma Questionnaire (CTQ) in Brazilian Samples of Different Age Groups: Findings from Confirmatory Factor Analysis | 2.3 | 138 | Citations (PDF) |
| 203 | Public school teachers’ perceptions about mental health | 2.7 | 12 | Citations (PDF) |
| 204 | Systematic review of N-acetylcysteine in the treatment of addictions | 0.9 | 68 | Citations (PDF) |
| 205 | Influence of personality traits in coping skills in individuals with bipolar disorder | 0.7 | 5 | Citations (PDF) |
| 206 | Functioning in early and late stages of schizophrenia | 0.8 | 12 | Citations (PDF) |
| 207 | Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations | 3.9 | 252 | Citations (PDF) |
| 208 | Advancing biomarker research: utilizing ‘Big Data’ approaches for the characterization and prevention of bipolar disorder | 2.1 | 61 | Citations (PDF) |
| 209 | Early life stress and tumor necrosis factor superfamily in crack cocaine withdrawal | 2.9 | 28 | Citations (PDF) |
| 210 | The theory of bipolar disorder as an illness of accelerated aging: Implications for clinical care and research | 6.8 | 174 | Citations (PDF) |
| 211 | Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia | 2.2 | 57 | Citations (PDF) |
| 212 | Childhood maltreatment and inflammatory markers: a systematic review | 4.1 | 403 | Citations (PDF) |
| 213 | Diabetes Mellitus and Disturbances in Brain Connectivity: A Bidirectional Relationship? | 3.6 | 26 | Citations (PDF) |
| 214 | Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: A follow-up study in antipsychotic-naïve patients with first-episode psychosis | 2.9 | 13 | Citations (PDF) |
| 215 | Manic Symptoms in Youth: Dimensions, Latent Classes, and Associations With Parental Psychopathology | 2.3 | 18 | Citations (PDF) |
| 216 | Recognition of bipolar disorder type I before the first manic episode: challenges and developments | 2.8 | 13 | Citations (PDF) |
| 217 | Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia | 2.9 | 39 | Citations (PDF) |
| 218 | Do sleep abnormalities and misaligned sleep/circadian rhythm patterns represent early clinical characteristics for developing psychosis in high risk populations? | 6.8 | 63 | Citations (PDF) |
| 219 | Selfish brain and neuroprogression in bipolar disorder | 3.8 | 23 | Citations (PDF) |
| 220 | Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia | 2.9 | 97 | Citations (PDF) |
| 221 | Adipokines during early abstinence of crack cocaine in dependent women reporting childhood maltreatment | 3.1 | 25 | Citations (PDF) |
| 222 | First manic episode in a patient with breast cancer | 2.6 | 2 | Citations (PDF) |
| 223 | Bipolar Disorder and Metabolic Syndrome: A Systematic Review | 0.9 | 70 | Citations (PDF) |
| 224 | Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia | 2.3 | 71 | Citations (PDF) |
| 225 | Is there a role for curcumin in the treatment of bipolar disorder? | 0.7 | 23 | Citations (PDF) |
| 226 | Determinants of adherence to treatment in bipolar disorder: A comprehensive review | 4.5 | 147 | Citations (PDF) |
| 227 | Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies | 5.4 | 577 | Citations (PDF) |
| 228 | Adaptation of the Barriers to Access to Care Evaluation (BACE) scale to the Brazilian social and cultural context | 0.8 | 9 | Citations (PDF) |
| 229 | Translation and adaptation of the Bipolar Prodrome Symptom Scale-Retrospective: Patient Version to Brazilian portuguese | 0.8 | 2 | Citations (PDF) |
| 230 | Childhood maltreatment and coping in bipolar disorder. | 1.0 | 7 | Citations (PDF) |
| 231 | N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals | 3.6 | 24 | Citations (PDF) |
| 232 | Hair Cortisol and Stressful Life Events Retrospective Assessment in Crack Cocaine Users | 2.1 | 36 | Citations (PDF) |
| 233 | The Association between Childhood Adversity and Components of Metabolic Syndrome in Adults with Mood Disorders: Results from the International Mood Disorders Collaborative Project | 1.2 | 79 | Citations (PDF) |
| 234 | A theoretical framework informing research about the role of stress in the pathophysiology of bipolar disorder | 3.8 | 49 | Citations (PDF) |
| 235 | Novel therapeutic targets in depression: Minocycline as a candidate treatment | 2.2 | 176 | Citations (PDF) |
| 236 | Impact of Childhood Stress on Psychopathology | 0.9 | 86 | Citations (PDF) |
| 237 | Inflammatory cytokines as an underlying mechanism of the comorbidity between bipolar disorder and migraine | 0.7 | 28 | Citations (PDF) |
| 238 | Impact of comorbid migraine on the clinical course of bipolar disorder | 4.0 | 26 | Citations (PDF) |
| 239 | Translation and adaptation of Theory of Mind tasks into Brazilian portuguese | 0.8 | 12 | Citations (PDF) |
| 240 | The "selfish brain" hypothesis for metabolic abnormalities in bipolar disorder and schizophrenia | 0.8 | 14 | Citations (PDF) |
| 241 | Towards a multifactorial approach for prediction of bipolar disorder in at risk populations | 4.5 | 93 | Citations (PDF) |
| 242 | Cytokines in schizophrenia: Possible role of anti‐inflammatory medications in clinical and preclinical stages | 3.3 | 53 | Citations (PDF) |
| 243 | Insulin dysfunction and allostatic load in bipolar disorder | 2.8 | 59 | Citations (PDF) |
| 244 | Therapeutic potential of interleukin-6 antagonism in bipolar disorder | 0.7 | 34 | Citations (PDF) |
| 245 | The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder | 3.8 | 20 | Citations (PDF) |
| 246 | Association of biomarkers and depressive symptoms in schizophrenia | 1.9 | 41 | Citations (PDF) |
| 247 | Social cognition and Theory of Mind: Controversies and promises for understanding major psychiatric disorders. | 1.0 | 21 | Citations (PDF) |
| 248 | Comorbidades médicas em pacientes ambulatoriais com transtorno do humor bipolar tipo I | 0.7 | 3 | Citations (PDF) |
| 249 | Early intervention in psychosis: a map of clinical and research initiatives in Latin America | 0.9 | 33 | Citations (PDF) |
| 250 | Early intervention for bipolar disorder: current imperatives, future directions | 0.9 | 17 | Citations (PDF) |
| 251 | Long‐acting injectable risperidone in a bipolar patient submitted to bariatric surgery and intolerant to conventional mood stabilizers | 3.3 | 14 | Citations (PDF) |
| 252 | Childhood maltreatment and clinical outcomes of bipolar disorder | 4.1 | 205 | Citations (PDF) |
| 253 | Clinical correlates of eating disorder comorbidity in women with bipolar disorder type I | 4.5 | 39 | Citations (PDF) |
| 254 | Letter to the Editor: Adiposity as a possible mediator of low testosterone salivary levels in adolescent boys in prodromal stages of psychosis | 0.0 | 0 | Citations (PDF) |
| 255 | Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor | 2.1 | 14 | Citations (PDF) |
| 256 | New perspectives on coping in bipolar disorder. | 1.0 | 9 | Citations (PDF) |
| 257 | "Life Chart" retrospectivo: instrumento para assinalar graficamente a presença e a evolução do impacto funcional de episódios afetivos maníacos e depressivos | 0.7 | 2 | Citations (PDF) |
| 258 | Increased soluble tumor necrosis factor‐α receptors in patients with major depressive disorder | 3.3 | 84 | Citations (PDF) |
| 259 | Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder | 4.5 | 128 | Citations (PDF) |
| 260 | The potential use of biomarkers as an adjunctive tool for staging bipolar disorder | 3.8 | 153 | Citations (PDF) |
| 261 | Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder | 4.5 | 416 | Citations (PDF) |
| 262 | TNF-α as a molecular target in bipolar disorder | 3.8 | 150 | Citations (PDF) |
| 263 | Reported Calcium Intake is Reduced in Women with Preeclampsia | 1.3 | 18 | Citations (PDF) |
| 264 | Morte materna em hospital terciário do Rio Grande do Sul - Brasil: um estudo de 20 anos | 1.0 | 18 | Citations (PDF) |
| 265 | Insights into the Effects of Crack Abuse on the Human Metabolome Using a NMR Approach | 3.4 | 20 | Citations (PDF) |
| 266 | Prodromal and at-risk states for bipolar disorder: opportunities for prevention | 0.0 | 0 | Citations (PDF) |
| 267 | Ketogenic therapy for schizophrenia: evidence, mechanisms, and clinical perspectives | 3.8 | 7 | Citations (PDF) |
| 268 | Effects of the Ketogenic Diet on Gonadal Hormones: A Systematic Review | 5.6 | 1 | Citations (PDF) |
| 269 | Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models | 2.7 | 0 | Citations (PDF) |
